"JunkDNA" (98.7% of DNA in human) is not "Junk" - requiring a generalization of the "Gene concept". On http://www.junkdna.com website news items are posted (some of them reproduced here from http://www.junkdna.com/new_citations.html ) - to be discussed. My "two cents" is FractoGene (see similar website and upcoming book), a geometrization that has received now experimental support for its first prediction.

Monday, May 16, 2005

Major investment to biotechnology


By a GenomeWeb staff reporter
NEW YORK, Jan. 7 (GenomeWeb News) - Burrill & Company, a San Francisco-based life sciences merchant bank, is launching a $300-million to $500-million venture capital fund dedicated to biotechnology, personalized medicine, new diagnostics, and devices...

Burrill & Company currently has $500 million under management. BLSCF III is Burrill's third generation of venture funds.

(see full article at http://www.junkdna.com/new_citations.html )

posted by Dr. Andras J. Pellionisz at 9:31 AM

1 Comments:

Blogger Dr. Andras J. Pellionisz said...

Close to $1 Billion (just from one Venture Capital company in three rounds) is pouring into the Gold Mine of Post Genome Re-Tooling. The field is awash in money, but is rather dry in breakthrough algorithmic approaches that provide immediate mathematical and information science based applications - comment by Andras Pellionisz, 10th of January, 2005

9:34 AM

 

Post a Comment

<< Home